FDA recall, , High risk
Herbs Forever Ayurvedic Herbal Supplements
HerbsForever Hingwastik Churna and Gastro Care dietary supplements may contain undeclared wheat, posing a risk of serious allergic reactions.
Recall ended May 5, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Herbs Forever of Los Angeles, California, recalled HerbsForever- Gastro Care and HerbsForever- Hingwastika Churna, sold primarily on-line nationwide, because the products may contain an undeclared allergen ingredient (Wheat). The company began the recall on January 6, 2026, and announced it on January 9, 2026; the FDA added it to the Enforcement Report on January 14, 2026.
2 photos
What to do
If a code on your package is listed below:
- Email the firm at contact@
herbsforever.com for instructions on how to return the recalled products and receive a full refund.
Is yours affected?
Compare every listed detail under your product with its label.
A UPC is the number printed under a barcode.
HerbsForever- Gastro Care, Ayruvedic Herbal Supplement, 90 VEGE Capsules, Extract
- Strength
- 800 mg
- UPC
- 8 07814 00124 3
- Lot code
- 124-4
HerbsForever brand Hingwastika Extract 60 Veg capsules, extract 800 mg each capsule
- UPC
- 807814001335
- Best-by or expiration date
- April-2029
- Batch code
- 133-14
HerbsForever- Hingwastika Churna, Ayruvedic Herbal Supplement, 90 VEGE Capsules, 100 GMS
- UPC
- 8 07814 00622 4
- Lot code
- 622-2
Recall details
- Company began the recall
- Sold in
Product is sold primarily on-line nationwide.
- Company
- Herbs ForeverLos Angeles, California
- Hazard
- Undeclared wheat
- Risk
High risk
There is a reasonable chance that taking it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 98267
- Recall numbers
- H-0404-2026 to H-0405-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Announced by the company
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Recall ended
Archived
Summary updated
